Anaesthesist journal

Three of the 5 recovered within 72 hours, 1 within 1 month, and 1 had a visual blind spot that persisted at 1 month.

Anaesthesist journal

These tests correlate closely with dabigatran levels measured by the reference standard method, liquid chromatography-tandem mass spectrometry. Unfortunately, these assays are not widely available, particularly on an emergent basis 18, The TT is exquisitely sensitive to dabigatran, even at very low drug concentrations.

Thus, a normal TT excludes clinically relevant dabigatran levels, but a prolonged TT does not discriminate between clinically important and insignificant drug concentrations.

All laboratories that do not offer an around-the-clock assay for dabigatran quantification should be encouraged to offer the TT for rapid exclusion of clinically significant dabigatran levels. A prolonged aPTT suggests the presence of on-therapy or above on-therapy levels of dabigatran.

However, a normal aPTT does not exclude the presence of on-therapy Anaesthesist journal, especially when a relatively insensitive aPTT reagent is used 16,18, When the assay is calibrated with the drug of interest, the results correlate closely with plasma drug levels measured by liquid chromatography-tandem mass spectrometry.

Anaesthesist Impact Factor

When the Anaesthesist journal is calibrated with a low-molecular-weight heparin standard, it can be useful for excluding clinically important levels of drug, but not for quantitation.

If an anti-Xa assay is not available, the PT may be useful for qualitative assessment of edoxaban and rivaroxaban. A prolonged PT suggests on-therapy or above on-therapy levels for these agents. However, depending on the sensitivity of the PT reagent, a normal PT may not exclude on-therapy levels 18, A prolonged PT suggests the presence of clinically important apixaban levels, but a normal PT and aPTT do not exclude on-therapy or even above on-therapy levels of the drug 18— Managing Major Bleeds Anticoagulants and antiplatelet agents should be held and airway and large-bore intravenous access secured.

Reversal of OAC is recommended if an agent is available for most patients with major bleeding see section on OAC Reversalsbut obtaining and administering the reversal agent must not delay resuscitation and local hemostatic measures.

We recommend aggressive volume resuscitation using intravenous isotonic crystalloids such as 0. The goal should be restoration of hemodynamic stability. There does not appear to be a benefit of colloids over crystalloids Hypothermia and acidosis should be corrected, as they may worsen the coagulopathy and perpetuate the bleeding.

There is no evidence to support the use of one crystalloid solution over another 24 ; however, caution should be given to the development of hyperchloremia and hyperchloremic acidosis with administration of large volumes of saline. We recommend early involvement of the appropriate service e.

Supportive measures should include blood product transfusion when appropriate. Randomized trial data suggest that a restrictive compared with liberal transfusion strategy improves survival and reduces the risk of recurrent bleeding in patients presenting with severe acute upper GI bleeding In patients with underlying coronary artery disease, particularly those with acute coronary syndromes, a more liberal transfusion strategy is advised.

The protocols are variable 31and currently, many centers use goal-directed transfusion with thromboelastography or rotational thromboelastometry.

Early administration of tranexamic acid for trauma patients within the first 3 hours of presentation is associated with decreased bleeding and overall mortality, and should be considered Careful attention should be given to comorbidities that could worsen bleeding and subsequent outcome.

Because of their dependence on renal function for clearance, all of the DOACs have higher blood levels and longer half lives in patients with renal dysfunction. In patients with severe renal dysfunction, we recommend laboratory evaluation to detect residual anticoagulant activity see section on Laboratory Measurement following administration of a reversal agent and consideration of redosing if bleeding persists or recurs.

Patients with renal dysfunction are also at risk for uremia-associated platelet dysfunction and may benefit from administration of desmopressin acetate or cryoprecipitate and optimization of renal status with hemodialysis 34— Dabigatran is the only OAC that can be removed by hemodialysis.

Hepatic dysfunction may be associated with coagulopathy and may also affect bleeding by reducing metabolism of the anticoagulant. Direct factor Xa inhibitors are partially metabolized by the liver and have not been studied in patients with severe hepatic dysfunction.

PT, INR, and aPTT may not be reliable measures of hemostatic function in patients with liver disease; in this setting, viscoelastic testing such as thromboelastography or rotational thromboelastometry may be of value for assessment of hemostatic function along with hematology consultation 37— Consideration might be given to the use of an antifibrinolytic agent, such as tranexamic acid and epsilon aminocaproic acid.

In patients with portal hypertension and esophageal varices, plasma should be used cautiously, because large volumes may increase portal pressure and exacerbate bleeding Statuses/updates [27/8/17] Journal access issues: We are currently experiencing access issues with Minerva Anestiologica and the Journal of Opioid are working with our vendors to resolve this issue and hope to have a resolution soon.

Anaesthesist journal

For users after Journal of Opioid Management articles, it is possible for us to provides articles via the Library's Request an article service. Metamizole or dipyrone, is a painkiller, spasm reliever and fever paracetamol, it has minimal anti-inflammatory effects.

Impact Factor List of Journals | SCI Journal List | Journal Impact Factor

It is most commonly given by mouth or by injection. Although it is still available over-the-counter in some countries, it is now either prescription or banned in most developed countries, due to its potential for adverse events, including agranulocytosis.

Journal articles indexed in ANAESTHESIST 1 Free download full-text articles in the Journals. The journal also publishes commissioned reviews by an authority in a field of interest to those working in anaesthesiology, pain or intensive care.


Abstracts of scientific meetings, editorials, book reviews, news and notices are also included. Prof Rossaint is the editor-in chief of Der Anaesthesist.

Charles-Marc Samama, MD, PhD, FCCP. Angioedema induced by treatment with angiotensin-converting–enzyme (ACE) inhibitors accounts for one third of angioedema cases in the emergency room; it is usually manifested in the upper airway. Original Article from The New England Journal of Medicine — A Randomized Trial of Icatibant in ACE-Inhibitor–Induced Angioedema Kojda G, Stelter K.

Angiotensin-converting enzyme inhibitor.

Revistas Electrónicas – Instituto de Investigaciones Biomédicas